IGHV3-65

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, IGHV3-65 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated IGHV3-65 data layer compared with 1 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IGHV3-65 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated IGHV3-65 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, ACC, and SKCM are the cancer types where IGHV3-65 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSMedianAll0.7540.640<.001144view →
ACCOSTertileAll0.4770.892<.001135view →
SKCMOSMedianAll0.4610.284<.00166view →
BRCADFSMedianAll0.9650.933.00365view →
UVMOSTertileII,III,IV0.1890.729.00145view →
DLBCDFSTertileIII,IV0.0700.855.00840view →
READOSMedianII,III,IV0.9520.415.00735view →
UCECOSTertileIII,IV0.7560.523.03618view →
KIRPDFSTertileAll0.3430.660.01316view →
BLCADFSQuartileIII,IV0.6540.515.01911view →
CESCDFSMedianAll0.7900.688.03110view →
STADOSTertileIV0.9180.300.0363view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

IGHV3-65–HNSC (DFS)

Kaplan–Meier survival curve for IGHV3-65 RNA-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration